Patents by Inventor Muhammed Majeed

Muhammed Majeed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR MANAGEMENT OF ATROPHIC GASTRITIS AND COLITIS
    Publication number: 20200316143
    Abstract: The present invention discloses a method for therapeutic management of atrophic gastritis and colitis using a composition comprising Bacillus coagulans MTCC 5856 individually or in combination with anthocyanins. The invention further discloses a method for preventing neoplastic transformation of mucosal cells in gastro-intestinal tract and improving gut barrier function in mammals using a composition comprising Bacillus coagulans MTCC 5856 individually or in combination with anthocyanins.
    Type: Application
    Filed: June 17, 2020
    Publication date: October 8, 2020
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Sarang Bani, Anjali Pandey, Shaheem Majeed
  • METHOD AND COMPOSITION FOR THERAPEUTIC MANAGEMENT OF GLUTEN INTOLERANCE
    Publication number: 20200316140
    Abstract: The present invention discloses the potential of probiotic bacteria Bacillus coagulans individually or in combination with multi-enzyme complex for reducing gluten content in foods rich in gluten and for the increased utilization of gluten. The invention further discloses a method for the management of gluten intolerance using composition comprising Bacillus coagulans and multi-enzyme complex in mammals.
    Type: Application
    Filed: March 31, 2020
    Publication date: October 8, 2020
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Kirankumar Beede, Sivakumar Arumugam, Shaheen Majeed
  • STABLE PROBIOTIC COMPOSITION FOR THE MANAGEMENT OF LACTOSE INTOLERANCE
    Publication number: 20200316139
    Abstract: The present invention discloses a stable probiotic composition comprising Bacillus coagulans individually and/or in combination with multi-enzyme complex for the utilization of lactose and therapeutic management of lactose intolerance. It also discloses a method for the management of lactose intolerance using composition comprising Bacillus coagulans individually and/or in combination with multi-enzyme complex.
    Type: Application
    Filed: April 2, 2019
    Publication date: October 8, 2020
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Furqan Ali, Sivakumar Arumugam, Shaheen Majeed
  • Compositions for management of infections
    Patent number: 10792295
    Abstract: Disclosed are compositions containing at least 10% w/w or above of 1-O-galloyl-?-D-glucose (?-glucogallin) which additionally comprising of about 10% w/w to greater than 60% w/w total mucic acid gallates including mucic acid 1,4-lactone 5-O-gallate, mucic acid 2-O-gallate, mucic acid 6-Methyl ester 2-O-gallate, mucic acid 1-Methyl ester 2-O-gallate and ellagic acid, and a probiotic bacteria Bacillus coagulans MTCC 5856, individually or in combination for inhibiting the growth and managing infections of Helicobacter pylori.
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: October 6, 2020
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Sivakumar Arumugam, Furqan Ali, Shaheen Majeed
  • COMPOSITION FOR THERAPEUTIC MANAGEMENT OF HYPOMELANOTIC SKIN CONDITIONS
    Publication number: 20200276257
    Abstract: The present invention discloses a composition comprising Nigella sativa extract standardized to contain not less than 0.1% w/w thymoquinone and not less than 0.01% w/w thymohydroquinone, Coleus forskolii extract standardized to contain not less than 90% w/w forskolin and Piper nigrum extract standardized to contain not less than 95% w/w piperine extract for use in enhancing melanogenesis in mammalian cells. The invention also discloses the use of above mentioned composition in the therapeutic management of hypomelanotic skin conditions and in reducing the progression of depigmentation of skin in vitiligo in mammalian skin.
    Type: Application
    Filed: February 10, 2020
    Publication date: September 3, 2020
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Prasad M. Peethambaran, Lakshmi Mundkur
  • APHRODISIAC COMPOSITION AND MANAGEMENT OF MALE SEXUAL DYSFUNCTION
    Publication number: 20200268822
    Abstract: The present invention discloses a composition for the therapeutic management of male sexual dysfunction and related disorders. Specifically, the invention discloses a composition comprising 60-65% w/w Withania somnifera extract, 12-18% w/w Mucana pruriens extract, 5-10% w/w Coleus forskolii extract, 12-18% w/w Kaempferia parviflora extract, 0.1-2% w/w Piper nigrum extract, for use as an aphrodisiac.
    Type: Application
    Filed: April 17, 2019
    Publication date: August 27, 2020
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Sarang Bani, Anjali Pandey
  • Adaptogenic compositions and applications thereof
    Patent number: 10716823
    Abstract: Disclosed is the adaptogenic activity of boswellic acids-polysaccharide compositions derived from Boswellia serrata in combination with either (i) the concentrate of the liquid endosperm of Cocos nucifera or (ii) the extract of Emblica officinalis fruit standardized to contain 10% w/w and above of 1-O-galloyl-?-D-glucose (?-glucogallin).
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: July 21, 2020
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam
  • BIOACTIVE MOLECULES FROM OROXYLUM INDICUM AND THEIR THERAPEUTIC APPLICATIONS
    Publication number: 20200188350
    Abstract: The present invention discloses a composition comprising not less than 10% w/w of oroxylin A, not less than 10% w/w of baicalein and not less than 2% w/w of chrysin for use in the therapeutic management of epilepsy.
    Type: Application
    Filed: February 26, 2020
    Publication date: June 18, 2020
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam
  • BEVERAGE COMPOSITIONS CONTAINING BACILLUS COAGULANS MTCC 5856
    Publication number: 20200187519
    Abstract: The present invention discloses beverage compositions comprising probiotic Bacillus coagulans and water soluble prebiotic fibers that have been subjected to treatments under extreme stress, temperature and pressure conditions like brewing or aeration wherein the spore viability is maintained post said treatments.
    Type: Application
    Filed: February 26, 2020
    Publication date: June 18, 2020
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Sivakumar Arumugam, Furqan Ali, Shaheen Majeed
  • Stable probiotic composition containing MTCC 5856 and method of detection thereof
    Patent number: 10668115
    Abstract: Disclosed is a stable probiotic composition containing Bacillus coagulans MTCC 5856 exhibiting increased viability over wide range of pH and the use of flow cytometry method to enumerate the viable count of Bacillus coagulans MTCC 5856 under various environmental conditions.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: June 2, 2020
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Shaheen Majeed, Lakshmi Mundkur
  • SPENT TURMERIC -METHODS AND COMPOSITIONS THEREOF
    Publication number: 20200164019
    Abstract: The present invention relates to a process for the isolation of bioactive components from spent turmeric (Curcuma longa) and compositions comprising said bioactive components. Further, the present invention also elucidates the potent anti-inflammatory activity of said bioactive compositions and therapeutic applications thereof in rheumatoid arthritis.
    Type: Application
    Filed: July 17, 2018
    Publication date: May 28, 2020
    Inventors: Muhammed Majeed, Kaiyanam Nagabhushanam, Beena Bhat, Natarajan Sankaran
  • Liver protectant compositions and therapeutic applications
    Patent number: 10653643
    Abstract: The invention pertains to a composition comprising Curcuminoids and Garcinol for hepatoprotection. Specifically, the invention discloses a composition comprising 95% Curcuminoids and 20% Garcinol for the therapeutic management of Non-alcoholic fatty liver disease (NAFLD) and associated conditions like steatosis, Non-alcoholic steatoheapatitis (NASH), fibrosis and cirrhosis of the liver.
    Type: Grant
    Filed: March 21, 2019
    Date of Patent: May 19, 2020
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Lakshmi Mundkur
  • Beverage compositions containing Bacillus coagulans MTCC 5856
    Patent number: 10609935
    Abstract: The present invention discloses beverage compositions comprising probiotic Bacillus coagulans and water soluble prebiotic fibers that have been subjected to treatments under extreme stress, temperature and pressure conditions like brewing or aeration wherein the spore viability is maintained post said treatments.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: April 7, 2020
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Sivakumar Arumugam, Furqan Ali, Shaheen Majeed
  • Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof
    Patent number: 10588844
    Abstract: The present disclosure provides oleanoyl tripeptide to prevent skin aging. More specifically the invention discloses the anti-collagenase, anti-elastase, enhancement of TGF-? secretion in fibroblasts, UV protection, oxidative stress protection, and other properties of the oleanoyl-KVK tripeptide which aids in preventing skin aging.
    Type: Grant
    Filed: September 19, 2018
    Date of Patent: March 17, 2020
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Lakshmi Mundkur, Rajendran Ramanujam
  • Composition containing Oroxylin A and method of extraction thereof
    Patent number: 10555982
    Abstract: Disclosed are the compositions comprising bioactive components Oroxylin A, Baicalein, Chrysin, and their glucuronides Oroxylin A-7-glucuronide, Baicalein-7-glucuronide and Chrysin-7-glucuronide, isolated from the bark of Oroxylum indicum, and the process of isolating the said bioactives.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: February 11, 2020
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Beena Bhat, Anurag Pande
  • Novel method for extraction of Oxyresveratrol from Artocarpus hirsutus
    Publication number: 20200039907
    Abstract: Disclosed is a novel method for extraction of Oxyresveratrol from Artocarpus hirsutus.
    Type: Application
    Filed: December 22, 2016
    Publication date: February 6, 2020
    Inventors: Muhammed MAJEED, Kalyanam NAGABHUSHANAM, Mahadeva NAYAK, Nagarajan ANANTHANARAYANAN
  • NATURAL MOLECULES FROM ARTOCARPUS HIRSUTUS: METHOD OF ISOLATION AND ANTI-ACNE POTENTIAL THEREOF
    Publication number: 20200038467
    Abstract: Method of isolating natural molecules: ? and ? pyranocycloartobiloxanthone A and Artonine E, from the stem bark of Artocarpus hirsutus and their anti-acne potential by inhibiting the growth of Propionibacterium acnes thereof, are described.
    Type: Application
    Filed: December 22, 2016
    Publication date: February 6, 2020
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Mahadeva Nayak, Nagarajan Ananthanarayanan
  • Telomerase enhancement potential of ecdysterone
    Patent number: 10548902
    Abstract: Disclosed is a method for enhancing the activity of telomerase using a composition containing ecdysterone. The invention also discloses the use of a composition containing ecdysterone and/or an extract containing ecdysterone, isolated from a plant source in preventing/delaying cell aging in mammals by increasing the activity of telomerase.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: February 4, 2020
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Lakshmi Mundkur
  • COMPOSITIONS FOR MODIFYING GUT MICROBIOTA
    Publication number: 20200030388
    Abstract: The present invention pertains to a composition comprising garcinol individually or in combination with forskolin for modifying the gut microbial diversity. More specifically, the invention relates to the use of composition comprising garcinol and forskolin for decreasing the Firmicutes/Bacteroidetes ratio and increasing the count of beneficial microbe, Akkermansia muciniphila.
    Type: Application
    Filed: September 30, 2019
    Publication date: January 30, 2020
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Lakshmi Mundkur
  • PROCESS FOR THE ISOLATION OF NOVEL GLYCOSIDES FROM PTEROCARPUS MARSUPIUM AND THEIR THERAPEUTIC EFFECTS
    Publication number: 20200024296
    Abstract: The present invention discloses a composition comprising not less than 5% w/w Pterocarpus marsupium extract standardized to contain not less than 0.5% w/w Pterocarposide and not less than 0.5% w/w Sabioside and a method for isolating the same. The invention also discloses a method of activating AMPK and inhibiting glucose production in mammalian cells using the aforementioned composition.
    Type: Application
    Filed: July 18, 2019
    Publication date: January 23, 2020
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam